by Metrix | Nov 2, 2018 | Metrix news
AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure. AELIX Therapeutics will investigate the safety, immunogenicity, and efficacy of AELIX Therapeutics’...
by Metrix | Jun 1, 2018 | Metrix news
Northern Biologics Inc., a developer of first-in-class immuno-oncology products, today announced that its lead immuno-oncology antibody, MSC-1, began clinical testing at Memorial Sloan Kettering Cancer Center with plans to soon expand to other world-leading sites in...
by Metrix | Apr 12, 2018 | Metrix news
Location intelligence SaaS company, Geoblink, has today announced that it has secured a $6m boost from Elaia Partners and existing investor Nauta Capital. The round includes grants from the Government of Madrid and Neotec CDTI, a public organisation for...
by Metrix | Feb 19, 2018 | Metrix news
Note: this article was originally published in Medium by Christophe Janz, from Point Nine Capital What does it take to raise capital, in SaaS, in 2018? UPDATE: The 2018 napkin has been published. You can download (and upvote 😉 ) it...
by Metrix | Feb 19, 2018 | Metrix news
Post originally published in Nauta Capital’s blog on 06 Dec 2017 ForceManager raises $12m in Series B Funding led by AXA Strategic Ventures Barcelona, 6th December 2017 – ForceManager, the first AI conversational sales assistant app for field sales teams,...
